Literature DB >> 29027356

Relationship between neighborhood socioeconomic status and venous thromboembolism: results from a population-based study.

D Kort1, N van Rein2, F J M van der Meer3, H W Vermaas4, N Wiersma5, S C Cannegieter1, W M Lijfering1.   

Abstract

Essentials Literature on socioeconomic status (SES) and incidence of venous thromboembolism (VTE) is scarce. We assessed neighborhood SES with VTE risk in a population of over 1.4 million inhabitants. Higher neighborhood SES was associated with lower incidence of VTE. These findings are helpful to inform policy and resource allocation in health systems.
SUMMARY: Background The association between socioeconomic status and arterial cardiovascular disease is well established. However, despite its high burden of disability-adjusted life years, little research has been carried out to determine whether socioeconomic status is associated with venous thromboembolism. Objective To determine if neighborhood socioeconomic status is associated with venous thromboembolism in a population-based study from the Netherlands. Methods We identified all patients aged 15 years and older with a first event of venous thromboembolism from inhabitants who lived in the urban districts of The Hague, Leiden and Utrecht in the Netherlands in 2008-2012. Neighborhood socioeconomic status was based on the status score, which combines educational level, income and unemployment on a four-digit postal code level. Incidence rate ratios of venous thromboembolism were calculated for different levels of neighborhood socioeconomic status, with adjustments for age and sex. Results A total of 7373 patients with a first venous thromboembolism (median age 61 years; 50% deep vein thrombosis) were identified among more than 1.4 million inhabitants. Higher neighborhood SES was associated with lower incidence of VTE. In the two highest status score groups (i.e. the 95-99th and > 99th percentile), the adjusted incidence rate ratios were 0.91 (95% confidence interval [CI], 0.84-1.00) and 0.80 (95% CI, 0.69-0.93), respectively, compared with the reference status score group (i.e. 30-70th percentile). Conclusions High neighborhood socioeconomic status is associated with a lower risk of first venous thromboembolism.
© 2017 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  epidemiology; incidence; risk; social class; venous thromboembolism

Mesh:

Year:  2017        PMID: 29027356     DOI: 10.1111/jth.13868

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  13 in total

1.  Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor Study.

Authors:  Radhika Gangaraju; Yanjun Chen; Lindsey Hageman; Jessica Wu; Liton Francisco; Kevin Battles; Michelle Kung; Emily Ness; Mariel Parman; Daniel J Weisdorf; Stephen J Forman; Mukta Arora; Saro H Armenian; Smita Bhatia
Journal:  Biol Blood Marrow Transplant       Date:  2019-07-03       Impact factor: 5.742

2.  Perspectives: on Precision Nutrition Research in Heart, Lung, and Blood Diseases and Sleep Disorders.

Authors:  Charlotte A Pratt; Alison G M Brown; Shilpy Dixit; Nicole Farmer; Aruna Natarajan; Josephine Boyington; Scarlet Shi; Qing Lu; Paul Cotton
Journal:  Adv Nutr       Date:  2022-10-02       Impact factor: 11.567

3.  Thromboembolic Events in a Socio-Economically Disadvantaged Population with COVID-19 Admitted to a Medicalized Hotel in Madrid.

Authors:  Karen Lizzette Ramírez-Cervantes; Consuelo Huerta-Álvarez; Manuel Quintana-Díaz
Journal:  Int J Environ Res Public Health       Date:  2022-06-25       Impact factor: 4.614

Review 4.  Epidemiology and prevention of venous thromboembolism.

Authors:  Pamela L Lutsey; Neil A Zakai
Journal:  Nat Rev Cardiol       Date:  2022-10-18       Impact factor: 49.421

Review 5.  Sex matters: Practice 5P's when treating young women with venous thromboembolism.

Authors:  Ingrid M Bistervels; Luuk J J Scheres; Eva N Hamulyák; Saskia Middeldorp
Journal:  J Thromb Haemost       Date:  2019-07-23       Impact factor: 5.824

Review 6.  COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.

Authors:  Behnood Bikdeli; Mahesh V Madhavan; David Jimenez; Taylor Chuich; Isaac Dreyfus; Elissa Driggin; Caroline Der Nigoghossian; Walter Ageno; Mohammad Madjid; Yutao Guo; Liang V Tang; Yu Hu; Jay Giri; Mary Cushman; Isabelle Quéré; Evangelos P Dimakakos; C Michael Gibson; Giuseppe Lippi; Emmanuel J Favaloro; Jawed Fareed; Joseph A Caprini; Alfonso J Tafur; John R Burton; Dominic P Francese; Elizabeth Y Wang; Anna Falanga; Claire McLintock; Beverley J Hunt; Alex C Spyropoulos; Geoffrey D Barnes; John W Eikelboom; Ido Weinberg; Sam Schulman; Marc Carrier; Gregory Piazza; Joshua A Beckman; P Gabriel Steg; Gregg W Stone; Stephan Rosenkranz; Samuel Z Goldhaber; Sahil A Parikh; Manuel Monreal; Harlan M Krumholz; Stavros V Konstantinides; Jeffrey I Weitz; Gregory Y H Lip
Journal:  J Am Coll Cardiol       Date:  2020-04-17       Impact factor: 24.094

7.  Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19.

Authors:  Galit H Frydman; Edward W Boyer; Rosalynn M Nazarian; Elizabeth M Van Cott; Gregory Piazza
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

8.  Current and future burden of venous thrombosis: Not simply predictable.

Authors:  Luuk J J Scheres; Willem M Lijfering; Suzanne C Cannegieter
Journal:  Res Pract Thromb Haemost       Date:  2018-04-17

9.  Dutch trends in the use of potentially harmful medication during pregnancy.

Authors:  Eline Houben; Bernke Te Winkel; Eric A P Steegers; Ron M C Herings
Journal:  Br J Clin Pharmacol       Date:  2020-05-26       Impact factor: 4.335

10.  Antithrombotic Preventive Medication Prescription Redemption and Socioeconomic Status in Hungary in 2016: A Cross-Sectional Study.

Authors:  Attila Juhász; Csilla Nagy; Orsolya Varga; Klára Boruzs; Mária Csernoch; Zoltán Szabó; Róza Ádány
Journal:  Int J Environ Res Public Health       Date:  2020-09-19       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.